Concepedia

Publication | Open Access

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

DOIFull Paper Access

2.5K

Citations

30

References

2005

Year

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Façon, Jean‐Luc Harousseau, Dina Ben‐Yehuda, Sagar Lonial, Hartmut Goldschmidt,
New England Journal of Medicine

Abstract

Bortezomib is superior to high-dose dexamethasone for the treatment of patients with multiple myeloma who have had a relapse after one to three previous therapies.

References

YearCitations

Page 1